Fonte: Npj breast cancer. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, METÁSTASE NEOPLÁSICA, BIOMARCADORES, METILAÇÃO DE DNA, PROTO-ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANDREY, Elisa H. F et al. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. Npj breast cancer, v. 5, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41523-019-0106-x. Acesso em: 07 nov. 2024.APA
Jandrey, E. H. F., Moura, R. P., Andrade, L. N. S., Machado, C. L., Campesato, L. F., Leite, K. R. M., et al. (2019). NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. Npj breast cancer, 5. doi:10.1038/s41523-019-0106-xNLM
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, Brentani HP, Chammas R. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients [Internet]. Npj breast cancer. 2019 ; 5[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/s41523-019-0106-xVancouver
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, Brentani HP, Chammas R. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients [Internet]. Npj breast cancer. 2019 ; 5[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/s41523-019-0106-x
